Hemophagocytic lymphohistiocytosis as a presentation of inflammatory bowel disease

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Background: Hemophagocytic lymphohistiocytosis (HLH) is considered a medical emergency that should be recognized in patients with fever, splenomegaly, and progressive deterioration of the general condition. Laboratory findings include cytope-nia, hypertriglyceridemia, hypofibrinogenemia, and hyperferritinemia. For HLH diagnosis, it is essential, although not mandatory, to perform a bone marrow biopsy. Given its nature, secondary causes of HLH should be sought, mainly infections, hemato-oncological disorders, autoimmune diseases, and auto-inflammatory conditions. Case report: We present the case of a female adolescent who presented with fever and lower gastrointestinal bleeding. Upon admission, acute liver failure and pancytopenia were documented. A bone marrow aspirate was performed, which revealed hemophagocytosis; other tests confirmed HLH diagnosis. During the diagnostic approach, inflammatory bowel disease was diagnosed. The patient received first-line treatment with an adequate response. Conclusions: Inflammatory bowel disease can be considered a cause of secondary HLH, particularly in patients with suggestive symptoms, such as digestive bleeding in the absence of other secondary causes of HLH.

Cite

CITATION STYLE

APA

Chávez-Aguilar, L. A., Flores-Villegas, V., & Zaragoza-Arévalo, G. R. (2020). Hemophagocytic lymphohistiocytosis as a presentation of inflammatory bowel disease. Boletin Medico Del Hospital Infantil de Mexico, 77(4), 207–211. https://doi.org/10.24875/BMHIM.20000013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free